Meera Saxena

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteers.

Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteers.

Journal: Antimicrobial agents and chemotherapy
Published: February 18, 2026

Full-length merozoite surface protein 1 formulated with GLA-SE adjuvant in malaria pre-exposed adults: a randomised, controlled, double-blind, parallel-group, single-centre Phase Ib trial.

Full-length merozoite surface protein 1 formulated with GLA-SE adjuvant in malaria pre-exposed adults: a randomised, controlled, double-blind, parallel-group, single-centre Phase Ib trial.

Journal: EClinicalMedicine
Published: July 07, 2025

Targeted apoptotic immune modulator for the treatment of metastatic EGFR-positive solid tumors.

Targeted apoptotic immune modulator for the treatment of metastatic EGFR-positive solid tumors.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 29, 2025

Parsing β-catenin's cell adhesion and Wnt signaling functions in malignant mammary tumor progression.

Parsing β-catenin's cell adhesion and Wnt signaling functions in malignant mammary tumor progression.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 19, 2021

The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis.

The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis.

Journal: Oncogene
Published: April 19, 2021

The long non-coding RNA ET-20 mediates EMT by impairing desmosomes in breast cancer cells.

The long non-coding RNA ET-20 mediates EMT by impairing desmosomes in breast cancer cells.

Journal: Journal of cell science
Published: January 23, 2021

Author Correction: PyMT-1099, a versatile murine cell model for EMT in breast cancer.

Author Correction: PyMT-1099, a versatile murine cell model for EMT in breast cancer.

Journal: Scientific reports
Published: July 08, 2020

A Pygopus 2-Histone Interaction Is Critical for Cancer Cell Dedifferentiation and Progression in Malignant Breast Cancer.

A Pygopus 2-Histone Interaction Is Critical for Cancer Cell Dedifferentiation and Progression in Malignant Breast Cancer.

Journal: Cancer research
Published: September 17, 2019

A Hierarchical Regulatory Landscape during the Multiple Stages of EMT.

A Hierarchical Regulatory Landscape during the Multiple Stages of EMT.

Journal: Developmental cell
Published: July 03, 2018

PyMT-1099, a versatile murine cell model for EMT in breast cancer.

PyMT-1099, a versatile murine cell model for EMT in breast cancer.

Journal: Scientific reports
Published: July 02, 2018

AMP-activated protein kinase promotes epithelial-mesenchymal transition in cancer cells through Twist1 upregulation.

AMP-activated protein kinase promotes epithelial-mesenchymal transition in cancer cells through Twist1 upregulation.

Journal: Journal of cell science
Published: July 11, 2017

A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.

A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.

Journal: Oncogene
Published: June 19, 2017
Showing 1-12 of 16

Last Updated: 09/26/2026